Acute Crit Care.  2022 Aug;37(3):477-479. 10.4266/acc.2021.01431.

Tacrolimus toxicity-related chorea in an infant after liver transplantation

• Kahveci F
• Kendirli T
• Gurbanov A
• Botan E
• Koloğlu M
• Bektaş Ö
• Kuloglu Z
• Balcı D
• Kansu A

• KMID: 2535314
• DOI: http://doi.org/10.4266/acc.2021.01431

Reference

1. Op den Buijsch RA, Christiaans MH, Stolk LM, Vries JE, Cheung CY, Undre NA, et al. Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms. Fundam Clin Pharmacol. 2007; 21:427–35.

2. Dawson TM. Immunosuppressants, immunophilins, and the nervous system. Ann Neurol. 1996; 40:559–60.

3. Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2008; 29:447–55.

4. Mroué A, Azar H. Improvement of a post pump chorea after switching to a low dose tacrolimus regimen in a kidney transplant recipient: a case report. J Urol Ren Dis. 2018; 198.

5. Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004; 43:623–53.